In the news release, FDA Approves Expanded Use of Lilly's (NYSE: LLY) FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid...
First and only FDA-approved anabolic agent in the U.S. now indicated to treat the leading type of secondary osteoporosis INDIANAPOLIS, July 23...
Ranking Featured Oklahoma's Innovative SoonerPSYCH Program OKLAHOMA CITY, July 21 /PRNewswire-FirstCall/ -- Over the past three years, Oklahoma...
SAN DIEGO, INDIANAPOLIS and CAMBRIDGE, Mass., July 7 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc., (NASDAQ:AMLN), Eli Lilly and...
INDIANAPOLIS, July 6 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE:LLY) will announce its financial results for the second quarter of...
Leading health care organizations help Ohioans live healthier lives INDIANAPOLIS, July 6 /PRNewswire-FirstCall/ -- Several area health care...
INDIANAPOLIS, June 22 /PRNewswire-FirstCall/ -- The board of directors of Eli Lilly and Company (NYSE:LLY) today declared a dividend for the...
Goal is to foster open collaboration between Lilly and global laboratory researchers INDIANAPOLIS, June 15 /PRNewswire-FirstCall/ -- Alzheimer's...
ADELPHI, Md., June 10 /PRNewswire-FirstCall/ -- The U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC...
Medicaid Pharmacy Management Program Improves Patient Care While Saving Eight States Almost $95 Million INDIANAPOLIS, June 8...
NEW ORLEANS, June 6 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) announced today new, positive Phase II study results of...
ORLANDO, Fla., May 31 /PRNewswire-FirstCall/ -- Eli Lilly and Company announced today that Phase III trial data showed the addition of Lilly's...
DALLAS, May 21 /PRNewswire/ -- BeaconEquity.com announces availability of stock alerts on companies making ground in today's market, issuing...
Collaboration combines insulin expertise of Lilly with Medtronic delivery and glucose sensing leadership INDIANAPOLIS and MINNEAPOLIS, May 19...
Three-year data show olanzapine LAI safety findings consistent with oral olanzapine except for injection-related events INDIANAPOLIS, May 18...
Support
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads